THE METAL CLIPS AS BREAST CANCER MARKERS IN ASSESSMENT OF RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY

被引:0
|
作者
Gambarova, G. H. [1 ]
Asgarova, H. E. [1 ]
Aghamaliyeva, A. J. [1 ]
Panahova, M. S. [1 ]
Agabeyli, L. Z. [1 ]
Qorchiyeva, G. S. [1 ]
机构
[1] Azerbaijan Med Univ, Baku, Azerbaijan
来源
WORLD OF MEDICINE AND BIOLOGY | 2024年 / 88卷 / 02期
关键词
chemotherapy. breast malignancy; breast conservative surgery; pathologic complete remission; radiodense marker; LOCALIZATION;
D O I
10.26724/2079-8334-2024-2-88-28-32
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
mic.amu@mail.ru The purpose of the study was to investigate the features of using surgical clips as tumor localization markers in patients with breast cancer and influence responses after neoadjuvant chemotherapy. 14 patients (16 lesions) underwent preoperative ultrasonography-guided surgical clip insertion before neoadjuvant chemotherapy. Within the 8-10 -day period before surgery follow-up mammography, ultrasonography and magnetic resonance imaging were performed to evaluate treatment response after neoadjuvant chemotherapy. 10 lesions underwent breast conservative surgery, the rest - 6 lesions were treated with modified radical mastectomy. There was no difficulty in the pathological evaluation of a specimen due to inserted surgical clips. The time interval from clip insertion to mammography after procedure and surgery was 38.1 +/- 12.4 days and 115.7 +/- 28.4 days, respectively. The mean number of inserted clips was 2.1 +/- 0.8. Our results have shown that surgical clips are helpful in visualization of tumors and their localization by various imaging methods, well tolerated and safe for the patient, do not interfere with treatment response after neoadjuvant chemotherapy.
引用
收藏
页码:28 / 32
页数:5
相关论文
共 50 条
  • [31] Assessment of breast cancer response to neoadjuvant chemotherapy: Is volumetric MRI a reliable tool?
    Lorenzon, Michele
    Zuiani, Chiara
    Londero, Viviana
    Linda, Anna
    Furlan, Alessandro
    Bazzocchi, Massimo
    EUROPEAN JOURNAL OF RADIOLOGY, 2009, 71 (01) : 82 - 88
  • [32] Response to immunohistochemical markers’ conversion after neoadjuvant chemotherapy in breast cancer patients: association between imaging and histopathologic analysis
    Y. Zhao
    X. Wang
    Y. Huang
    X. Zhou
    D. Zhang
    Clinical and Translational Oncology, 2020, 22 : 91 - 102
  • [33] Response to immunohistochemical markers' conversion after neoadjuvant chemotherapy in breast cancer patients: association between imaging and histopathologic analysis
    Zhao, Y.
    Wang, X.
    Huang, Y.
    Zhou, X.
    Zhang, D.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (01): : 91 - 102
  • [34] Improving pathological complete response in luminal breast cancer after neoadjuvant chemotherapy
    Cudos, Ariadna Gasol
    Murillo, Serafin Morales
    Galindo, Alvaro Rodriguez
    Subirats, Ona Pallise
    Olive, Jordi Mele
    Morales, Carles Canosa
    Villellas, Felip Vilardell
    Guzman, Douglas Rene Sanchez
    Rodriguez, Joel Veas
    CANCER RESEARCH, 2022, 82 (04)
  • [35] Breast cancer phenotype influences MRI response evaluation after neoadjuvant chemotherapy
    Negrao, Erika M. S.
    Souza, Juliana A.
    Marques, Elvira F.
    Bitencourt, Almir G., V
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 120
  • [36] Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Mueller, Carolin
    Schmidt, Gilda
    Juhasz-Boess, Ingolf
    Jung, Lisa
    Huwer, Sarah
    Solomayer, Erich-Franz
    Juhasz-Boess, Stephanie
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 304 (04) : 1065 - 1071
  • [37] Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Carolin Müller
    Gilda Schmidt
    Ingolf Juhasz-Böss
    Lisa Jung
    Sarah Huwer
    Erich-Franz Solomayer
    Stephanie Juhasz-Böss
    Archives of Gynecology and Obstetrics, 2021, 304 : 1065 - 1071
  • [38] Pathologic complete response after neoadjuvant chemotherapy in breast cancer molecular subtypes
    Sari, E.
    Aksoy, S.
    Dogan, M.
    Altinbas, M.
    Zengin, N.
    Ozisik, Y.
    Altundag, K.
    BREAST, 2015, 24 : S99 - S99
  • [39] Role for surgery after complete clinical response to neoadjuvant chemotherapy for breast cancer
    Le Bouëdec, G
    Charrier, S
    Curé, H
    de Latour, MP
    Ferrière, JP
    Chollet, P
    Dauplat, J
    PRESSE MEDICALE, 1999, 28 (39): : 2145 - 2148
  • [40] should radiotherapy be avoided after neoadjuvant chemotherapy in complete response breast cancer?
    Arenas Prat, M.
    Sabater, S.
    Bonet, M.
    Gascon, M.
    Gomez, D.
    Arquez, M.
    Torres, L.
    Gomez, J.
    Amillano, K.
    Mele, M.
    De la Flor, M.
    Rodriguez, E.
    Camps, J.
    Joven, J.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1271 - S1271